<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="22/11/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8799177" creator="Junko Matsuura">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>8799177</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Other" id="T1" lex="Epstein-Barr_viral_latency"><term sem="Virus" id="T39">Epstein-Barr viral</term> latency</term> is disrupted by the <term sem="Protein_molecule" id="T2" lex="immediate-early_BRLF1_protein">immediate-early BRLF1 protein</term> through a <term sem="Other" id="T3" lex="cell-specific_mechanism">cell-specific mechanism</term>.</sentence>
<event id="E1">
<type class="Negative_regulation" />
<theme idref="T1" />
<cause idref="T2" />
<clue>Epstein-Barr viral latency is <clueType>disrupted</clueType> <linkCause>by</linkCause> the immediate-early BRLF1 protein through a cell-specific mechanism.</clue>
</event>
<event id="E2">
<type class="Positive_regulation" />
<theme idref="E1" />
<cause idref="T3" />
<clue>Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein <linkCause>through</linkCause> a cell-specific mechanism.</clue>
<comment>NO CLUETYPE</comment>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Virus" id="T4" lex="Epstein-Barr_virus">Epstein-Barr virus</term> (<term sem="Virus" id="T5" lex="EBV">EBV</term>), the causative agent of <term sem="Other" id="T6" lex="infectious_mononucleosis">infectious mononucleosis</term>, is a <term sem="Virus" id="T7" lex="human_herpesvirus">human herpesvirus</term> associated with <term sem="Other" id="T8" lex="epithelial_cell_malignancy"><term sem="Cell_natural" id="T33">epithelial cell</term> malignancies</term> (<term sem="Other" id="T9" lex="nasopharyngeal_carcinoma">nasopharyngeal carcinoma</term>) as well as <term sem="Other" id="T10" lex="B-cell_malignancy"><term sem="Cell_natural" id="T32">B-cell</term> malignancies</term>.</sentence>
<event id="E3">
<type class="Positive_regulation" />
<theme idref="T6" />
<cause idref="T5" />
<clue>Epstein-Barr virus (EBV), the <clueType>causative</clueType> agent <linkTheme>of</linkTheme> infectious mononucleosis, is a human herpesvirus associated with epithelial cell malignancies (nasopharyngeal carcinoma) as well as B-cell malignancies.</clue>
</event>
<event id="E4">
<type class="Correlation" />
<theme idref="T5" />
<theme idref="T8" />
<clue>Epstein-Barr virus (EBV), the causative agent of infectious mononucleosis, is a human herpesvirus <clueType>associated</clueType> <linkTheme>with</linkTheme> epithelial cell malignancies (nasopharyngeal carcinoma) as well as B-cell malignancies.</clue>
</event>
<event id="E5">
<type class="Correlation" />
<theme idref="T5" />
<theme idref="T9" />
<clue>Epstein-Barr virus (EBV), the causative agent of infectious mononucleosis, is a human herpesvirus <clueType>associated</clueType> <linkTheme>with</linkTheme> <corefTheme idref1="T9">epithelial cell malignancies</corefTheme> (nasopharyngeal carcinoma) as well as B-cell malignancies.</clue>
</event>
<event id="E6">
<type class="Correlation" />
<theme idref="T5" />
<theme idref="T10" />
<clue>Epstein-Barr virus (EBV), the causative agent of infectious mononucleosis, is a human herpesvirus <clueType>associated</clueType> <linkTheme>with</linkTheme> epithelial cell malignancies (nasopharyngeal carcinoma) as well as B-cell malignancies.</clue>
</event>
<sentence id="S3">Understanding how <term sem="Other" id="T11" lex="viral_latency"><term sem="Virus" id="T40">viral</term> latency</term> is disrupted is a central issue in <term sem="Other" id="T12" lex="herpesvirus_biology"><term sem="Virus" id="T34">herpesvirus</term> biology</term>.</sentence>
<event id="E7">
<type class="Negative_regulation" />
<theme idref="T11" />
<clue>Understanding how viral latency is <clueType>disrupted</clueType> is a central issue in herpesvirus biology.</clue>
</event>
<sentence id="S4"><term sem="Cell_natural" id="T35">Epithelial cells</term> are the major site of <term sem="Other" id="T13" lex="lytic_EBV_replication">lytic <term sem="Virus" id="T14" lex="EBV">EBV</term> replication</term> within the <term sem="Multicellular_organism_natural" id="T15" lex="human_host">human host</term>, and <term sem="Other" id="T36"><term sem="Virus" id="T37">viral</term> reactivation</term> occurs in <term sem="Virus" id="T17" lex="EBV">EBV</term>-associated <term sem="Other" id="T18" lex="nasopharyngeal_carcinoma">nasopharyngeal carcinomas</term>.</sentence>
<event id="E8">
<type class="Viral_life_cycle" />
<theme idref="T14" />
<clue><clueLoc>Epithelial cells</clueLoc> are the major site of <clueType>lytic</clueType> EBV <clueType>replication</clueType> <clueLoc>within the human host</clueLoc>, and viral reactivation occurs in EBV-associated nasopharyngeal carcinomas.</clue>
</event>
<event id="E9">
<type class="Viral_life_cycle" />
<theme idref="T14" />
<clue>Epithelial cells are the major site of lytic EBV replication within the human host, and <corefTheme>viral</corefTheme> <clueType>reactivation</clueType> occurs in EBV-associated nasopharyngeal carcinomas.</clue>
</event>
<event id="E10">
<type class="Correlation" />
<theme idref="E9" />
<theme idref="T16" />
<clue>Epithelial cells are the major site of lytic EBV replication within the human host, and viral reactivation <clueType>occurs</clueType> <linkTheme>in</linkTheme> EBV-associated nasopharyngeal carcinomas.</clue>
</event>
<event id="E11">
<type class="Correlation" />
<theme idref="T17" />
<theme idref="T18" />
<clue>Epithelial cells are the major site of lytic EBV replication within the human host, and viral reactivation occurs in EBV-<clueType>associated</clueType> nasopharyngeal carcinomas.</clue>
</event>
<sentence id="S5">It is known that <term sem="Other" id="T16">expression</term> of a single <term sem="Protein_family_or_group" id="T19" lex="viral_immediate-early_protein">viral immediate-early protein</term>, <term sem="Protein_molecule" id="T20" lex="BZLF1">BZLF1</term>, is sufficient to initiate the switch from latent to <term sem="Other" id="T21" lex="lytic_infection">lytic infection</term> in <term sem="Cell_natural" id="T22" lex="B_cell">B cells</term>.</sentence>
<event id="E12">
<type class="Gene_expression" />
<theme idref="T20" />
<clue>It is known that <clueType>expression</clueType> of a single viral immediate-early protein, BZLF1, is sufficient to initiate the switch from latent to lytic infection in B cells.</clue>
</event>
<event id="E13">
<type class="Viral_life_cycle" />
<theme idref="T14" />
<theme idref="T22" />
<clue>It is known that expression of a single viral immediate-early protein, BZLF1, is sufficient to initiate the switch from latent to <clueType>lytic infection</clueType> <linkTheme>in</linkTheme> B cells.</clue>
<comment>NO COREFTHEME</comment>
</event>
<event id="E14">
<type class="Viral_life_cycle" />
<theme idref="T14" />
<theme idref="T22" />
<clue>It is known that expression of a single viral immediate-early protein, BZLF1, is sufficient to initiate the switch from <clueType>latent</clueType> to lytic <clueType>infection</clueType> <linkTheme>in</linkTheme> B cells.</clue>
<comment>NO COREFTHEME</comment>
</event>
<event id="E15">
<type class="Positive_regulation" />
<theme idref="E13" />
<clue>It is known that expression of a single viral immediate-early protein, BZLF1, is sufficient to initiate the <clueType>switch</clueType> from latent <linkTheme>to</linkTheme> lytic infection in B cells.</clue>
</event>
<event id="E16">
<type class="Negative_regulation" />
<theme idref="E14" />
<clue>It is known that expression of a single viral immediate-early protein, BZLF1, is sufficient to initiate the <clueType>switch</clueType> <linkTheme>from</linkTheme> latent to lytic infection in B cells.</clue>
</event>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="E15" />
<cause idref="E12" />
<clue>It is known that expression of a single viral immediate-early protein, BZLF1, is sufficient to <clueType>initiate</clueType> the switch from latent to lytic infection in B cells.</clue>
</event>
<event id="E18">
<type class="Positive_regulation" />
<theme idref="E16" />
<cause idref="E12" />
<clue>It is known that expression of a single viral immediate-early protein, BZLF1, is sufficient to <clueType>initiate</clueType> the switch from latent to lytic infection in B cells.</clue>
</event>
<sentence id="S6"><term sem="Other" id="T23" lex="cellular_regulation">Cellular regulation</term> of <term sem="Other" id="T24" lex="BZLF1_transcription"><term sem="Protein_molecule" id="T25" lex="BZLF1">BZLF1</term> transcription</term> is therefore thought to play a key role in regulating the stringency of <term sem="Other" id="T26" lex="viral_latency"><term sem="Virus" id="T41">viral</term> latency</term>.</sentence>
<event id="E19">
<type class="Transcription" />
<theme idref="T25" />
<clue>Cellular regulation of BZLF1 <clueType>transcription</clueType> is therefore thought to play a key role in regulating the stringency of viral latency.</clue>
</event>
<event id="E20">
<type class="Regulation" />
<theme idref="E19" />
<clue><clueLoc>Cellular</clueLoc> <clueType>regulation</clueType> <linkTheme>of</linkTheme> BZLF1 transcription is therefore thought to play a key role in regulating the stringency of viral latency.</clue>
</event>
<event id="E21">
<type class="Regulation" />
<theme idref="T26" />
<clue>Cellular regulation of BZLF1 transcription is therefore thought to play a key role in <clueType>regulating</clueType> the stringency of viral latency.</clue>
</event>
<event uncertainty="probable" id="E22">
<type class="Positive_regulation" />
<theme idref="E21" />
<cause idref="E20" />
<clue>Cellular regulation of BZLF1 transcription is therefore thought to <clueType>play a key role</clueType> <linkTheme>in</linkTheme> regulating the stringency of viral latency.</clue>
</event>
<sentence id="S7">Here we show that, unexpectedly, <term sem="Other" id="T38">expression</term> of another <term sem="Protein_family_or_group" id="T27" lex="viral_immediate-early_protein">viral immediate-early protein</term>, <term sem="Protein_molecule" id="T28" lex="BRLF1">BRLF1</term>, can disrupt <term sem="Other" id="T29" lex="viral_latency"><term sem="Virus" id="T42">viral</term> latency</term> in an <term sem="Cell_natural" id="T30">epithelial cell</term>-specific fashion.</sentence>
<event id="E23">
<type class="Gene_expression" />
<theme idref="T28" />
<clue>Here we show that, unexpectedly, <clueType>expression</clueType> <linkTheme>of</linkTheme> another viral immediate-early protein, BRLF1, can disrupt viral latency in an epithelial cell-specific fashion.</clue>
</event>
<event id="E24">
<type class="Negative_regulation" />
<theme idref="T29" />
<cause idref="E23" />
<clue>Here we show that, unexpectedly, expression of another viral immediate-early protein, BRLF1, can <clueType>disrupt</clueType> viral latency <clueLoc>in an epithelial cell</clueLoc>-specific fashion.</clue>
</event>
<sentence id="S8">Therefore, the <term sem="Other" id="A3">mechanisms</term> leading to disruption of <term sem="Other" id="A2"><term sem="Virus" id="T31" lex="EBV">EBV</term> latency</term> appear to be cell-type specific.</sentence>
<event id="E25">
<type class="Negative_regulation" />
<theme idref="A2" />
<clue>Therefore, the mechanisms leading to <clueType>disruption</clueType> <linkTheme>of</linkTheme> EBV latency appear to be cell-type specific.</clue>
</event>
<event id="E26">
<type class="Positive_regulation" />
<theme idref="E25" />
<cause idref="A3" />
<clue>Therefore, the mechanisms <clueType>leading</clueType> <linkTheme>to</linkTheme> disruption of EBV latency appear to be cell-type specific.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
